Related Experiment Video
Updated: Sep 6, 2025

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
The challenges in diagnosing pediatric primary antiphospholipid syndrome
Selcan Demir1, Armağan Keskin2, Erdal Sağ1
1Department of Pediatric Rheumatology, Faculty of Medicine, 64005Hacettepe University, Ankara, Turkey.
Insights
Pediatric primary antiphospholipid syndrome (APS) differs from adult APS. Specific criteria are needed for diagnosing pediatric APS to avoid missed or delayed diagnoses in children.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Hematology
Background:
- Pediatric primary antiphospholipid syndrome (APS) is rare and distinct from adult APS.
- Diagnosis in children often requires adapting adult criteria, potentially leading to delays.
Purpose of the Study:
- To present experience in diagnosing and treating pediatric primary APS.
- To highlight distinctions between pediatric and adult APS.
- To emphasize the need for specific diagnostic considerations in children.
Main Methods:
- Retrospective review of six pediatric primary APS cases.
- Application of updated Sapporo criteria for APS diagnosis.
- Analysis of clinical manifestations, including vascular, hematologic, neurologic, and psychiatric involvement.
Main Results:
- Six pediatric patients diagnosed with primary APS, one with probable catastrophic APS (CAPS).
- Manifestations included vascular events, thrombocytopenia, psychiatric disorders, chorea, and valvular heart disease.
- All patients received immunosuppression and long-term anticoagulation.
Conclusions:
- Pediatric primary APS presents unique features not covered by adult classification criteria.
- Neurologic and hematologic manifestations are common in pediatric APS.
- Current adult criteria may lead to underdiagnosis in pediatric populations, necessitating tailored diagnostic approaches.
Abstract:
Pediatric primary antiphospholipid syndrome (APS) is a very rare disease with significant distinctions from the APS in adults. Herein, we present our experience in the diagnosis and treatment of six pediatric primary APS patients, who met the updated Sapporo criteria for the APS diagnosis. One of them was also diagnosed as having probable catastrophic APS (CAPS) due to the involvement of three different organ systems simultaneously. Besides vascular involvement, four patients had thrombocytopenia, one had psychiatric disorder, and one had chorea and valvular heart disease. All patients received immunosuppressive treatment along with long-term anticoagulation therapy. Specific neurologic and hematologic manifestations that are not part of the classification criteria can be seen in children with primary APS. Therefore, using the adult criteria for diagnosing pediatric APS may result in missed or delayed diagnoses in children.
More Related Videos
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies